The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Improved laryngeal function after neoadjuvant therapy for advanced thyroid cancer: A potential outcome of interest for future clinical trials.
 
Amr Hesham Abdelhamid Ahmed
No Relationships to Disclose
 
Amanda Silver Karcioglu
No Relationships to Disclose
 
Zipei Feng
No Relationships to Disclose
 
David C. Shonka
No Relationships to Disclose
 
Ayaka J. Iwata
No Relationships to Disclose
 
Maria E. Cabanillas
Honoraria - Loxo/Lilly
Consulting or Advisory Role - Bayer; Exelixis; Ignyta; Lilly; Loxo
Research Funding - Eisai; Exelixis; Kura Oncology; Merck; Roche/Genentech
 
Lori J. Wirth
Consulting or Advisory Role - Bayer; Blueprint Medicines; Coherus Biosciences; Eisai; Exelixis; Lilly; Loxo; Merck; Morphic Therapeutic
Research Funding - Ayala Pharmaceuticals (Inst); Checkmate Pharmaceuticals (Inst); CUE Biopharma (Inst); Eisai (Inst); Lilly (Inst)
Expert Testimony - Eisai
Other Relationship - PDS Biotechnology
 
Mark E. Zafereo
Research Funding - Lilly; Merck
 
Gregory W. Randolph
Research Funding - Eisai (Inst)
Other Relationship - American College of Surgeons; American Head and Neck Society (AHNS); International Thyroid Oncology Group; World Congress on Thyroid Cancer (WCTC)